The SVP R&D of NanoString Tech (NASDAQ: NSTG) is Selling Shares

By Carrie Williams

Yesterday, the SVP R&D of NanoString Tech (NSTGResearch Report), Joseph Beechem, sold shares of NSTG for $662.3K.

In addition to Joseph Beechem, 3 other NSTG executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

The company has a one-year high of $86.42 and a one-year low of $24.87. Currently, NanoString Tech has an average volume of 483.89K. NSTG’s market cap is $3.14 billion and the company has a P/E ratio of -24.90.

Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $76.00, reflecting a -8.3% downside.

The insider sentiment on NanoString Tech has been negative according to 66 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.